AzTrials
AzTrials

Overweight and Obesity in SchoolchildrenCHildHNSNCT03309189

Swiss Childhood Health and Nutrition Survey

An observational study of Overweight and Obesity in Schoolchildren, run by Isabelle Herter-Aeberli at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Overweight and Obesity in Schoolchildren
How many people
2,292 participants
Where
1 siteSwitzerland
Study dates
17 Aug 2017to 30 Jun 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: All children at the selected schools and in the defined age range are eligible.

Who may be able to join

  • age between 6 and 12 years

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • ETH Zurich

    Zurich, 8092

Other trials in Switzerland

About this study

Official title: National Studie Gesundheit Und Ernährung Von Primarschülern

The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. In addition, a questionnaire will be used to assess data on physical activity, nutrition, health and socioeconomic background and waist circumference as well as skin fold thicknesses will be measured.

Medical subject headings
Overweight

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of overweight and obesity

    Based on weight and height measurements BMI z-scores will be calculated for the classification in the different weight status groups (underweight, normal weight, overweight, obese)

    Measured: 1 day of first visit

Secondary outcomes (6)
  1. Waist circumference

    Measured: 1 day of first visit

  2. body fat %

    Based on the measurement of skinfold thicknesses at 4 sites body fat % will be calculated

    Measured: 1 day of first visit

  3. Physical activity

    Assessed using a questionnaire

    Measured: 1 day of first visit

  4. Nutrition

    Assessed using a questionnaire

    Measured: 1 day of first visit

  5. General health

    Assessed using a questionnaire

    Measured: 1 day of first visit

  6. Socioeconomic background

    Assessed using a questionnaire

    Measured: 1 day of first visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Oct 2017
  2. Study start17 Aug 2017
  3. Primary completion31 Mar 2018
  4. Study completion30 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
2,292 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03309189
Sponsor's protocol ID
CHildHNS
Acronym
CHildHNS
Status last verified
Jul 2018
First submitted
18 Aug 2017
Last updated
13 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Overweight and Obesity in Schoolchildren, run by Isabelle Herter-Aeberli at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of overweight and obesity (time frame: 1 day of first visit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in